Complimentary COVID-19 testing and treatment for uninsured Americans to be phased out by the White House
After the White House and Congress permitted a federal programme that funded clinicians for coronavirus care to end this week, some not insured Americans will soon be on the look for COVID-19 testing, treatments.

The programme paid out more than $18 billion to providers for testing, treating, and vaccinating people without insurance over the span of two years, with $11.4 billion going to testing, $5.8 billion to medication, and $1.6 billion to immunizations.
Americans lacking medical insurance will have until April 5 to get the vaccine for free, after which the Health Resources and Service Administration will no longer accept payment applications. On Tuesday, the programme ceased taking payments for uninsured people's medication and tests.
More financing for the initiative has been requested by the White House and hospitals.
Biden's team pushed Congress earlier this month to appropriate an extra $22.8 billion in emergency funds for COVID-19 response measures, including funding the reimbursement programme and replenishing vaccine and antibody medicine stocks, threatening grave repercussions if lawmakers refused to do so.
According to the Census Bureau, there are around 28 million people without medical insurance. Without the reimbursement programme, uninsured COVID-19 patients' healthcare expenditures are based on hospital fees, which can vary substantially, and government assistance eligibility.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.